FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

ABBOTINDIA

16,874.1
-99.2 (-0.58%)
Updated 10:00 11/08 IST

ABBOTINDIA Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for ABBOTINDIA
Disclaimer
0% Bullish
0% Bearish

ABBOTINDIA Buy or Sell - Brokerage Reports

No. of reports in last year
2
No. of analysts
1
Average Consensus Forecast
12395
Consensus Potential
-41.41%
See ABBOTINDIA Share Price Targets >>

ABBOTINDIA Ratings

Long term ABBOTINDIA rating by FrontPage users
5/5 (2 Ratings)
Find answers to all your questions on live ABBOTINDIA message board: Is ABBOTINDIA buy or sell? Should I buy ABBOTINDIA shares? Why are ABBOTINDIA shares falling? Should I invest in ABBOTINDIA stock?

  1. Home
  2. ABBOTINDIA Forum

ABBOTINDIA Share Price Discussion


ABBOTT - Q1 FY21 (Unaudited – Cons.)
CMP: 16,200
Total income from operations 1,064 Cr
999 Cr (6.51%) YoY | 961 Cr (10.72%) QoQ
Year ending revenue: 4,093 Cr Vs. 3,679 Cr (11.27%)
Net Profit of 180.3 Cr
116.9 Cr (55.11%) YoY 110.9 Cr (63.53%) QoQ
Year endi...
Read more...
Like
Reply

FDC - Q1 FY21 (Unaudited – Cons.)
CMP: 340
Total income from operations 308 Cr
344 Cr (-10.51%) YoY | 333 Cr (-7.72%) QoQ
Year ending revenue: 1,344 Cr Vs. 1,089 Cr (23.47%)
Net Profit of 91.7 Cr
56.2 Cr (62.51%) YoY 55.5 Cr (64.53%) QoQ
Year ending Net profit: 2...
Read more...
Like
Reply

*Hindustan Petroleum Corporation Q1 (Standalone, QoQ)*
Revenue down 43% at Rs 37,720.8 crore (Est Rs 42,777 crore)
Net profit at Rs 2813.8 crore versus Rs 26.8 crore (Est Rs 1,523 crore)
Ebidta gain at Rs 4,354.2 cr versus Ebidta loss at Rs 706.7 crore (Est Ebidta g...
Read more...
Like
Reply

*Lupin* has signed exclusive distribution pact with Fordoz Pharma for granting the company, exclusive rights to market and distribute two complex injectable assets which are in advanced stages of development in the U.S. and its territories. The two assets are in the oncol...
Read more...
1
Reply

RBI allows banks to lend up to 90% against gold; Muthoot, Manappuram corrected
The RBI hiked the loan-to-value ratio on gold loans to provide relief to borrowers looking to take gold loans to mitigate the urgent financial needs caused by the Covid-19 pand...
Read more...
Like
Reply

TATA MOTORS: U.K. JLR JULY TOTAL SALES AT (+27%) 8476 UNITS VS 6668 UNITS (YOY) || LAND ROVER SALES AT (+38%) 5730 VS 4153 UNITS (YOY)
1
Reply

*Tata consumer very strong 1QFY21 results *
Overall Revenue at INT 2714 crore growth of 13.4%
Overall consolidated EBITDA up 38% YoY to INR 483 crore
Consolidated PBT before exceptional items up 42% YoY to INR 436 crore
Indian branded beverage business post 10% sal...
Read more...
1
Reply

Dixon Tech - Q1 FY21 (Unaudited – Cons.)
CMP: 8,000
Total income from operations 517 Cr
1,147 Cr (-54.91%) YoY | 857 Cr (-39.72%) QoQ
Year ending revenue: 4,400 Cr Vs. 2,984 Cr (47.47%)
Net Profit of 1.60 Cr
23.5 Cr (-93.41%) YoY 27.6 Cr (-94.23%) QoQ
Year endi...
Read more...
Like
Reply
S
Reputation: -67 • Aug 9 5:35 AM

ITC - 1131960

Bearish Harmonics.. Sell level 200 - 201.. SL @ 202.5 or 10 mins candle's closing basis.
TGT - Up to you..
Like
Reply
S
Reputation: -67 • Aug 8 5:20 AM

AXISBANK - 1131957

Bearish Harmonics. Short sell @ 444 to 446. SL @ 10 mins candle closing or 447.
TGT - up to you...
Like
Reply
S
Reputation: -67 • Aug 8 5:11 AM

AMARAJABAT - 1131956

Testing 722 levels several times.. Break out in coming days is very much possible. Would be a good RR trade for sure. If sustains above 722 then 7(49) is possible.
Like
Reply
Rights issue vs bonus issue: Do they come really as a bonanza?
Investors should never consider a rights issue just because it comes at a discount. They need to also look at other factors.
The Economic Times
Like
Reply
N
Reputation: 4,721 • Aug 8 4:43 AM
TVS Electronics slips into red, posts loss Rs 9.75 crore in June quarter
The company had registered a profit of Rs 1.97 crore in the same period a year ago.
Moneycontrol
Like
Reply
Tata Consumer’s shares re-rate after Q1FY21; valuations match Britannia
Around 90% of its revenues came from branded business, of which India beverages and foods sales together contributed 65%. The Indian beverages business grew 11%, benefitting from the strong double-digit growth in May and June. The India foods segment grew 19%
https://www.livemint.com
1
Reply
N
Reputation: 4,721 • Aug 8 4:03 AM
IndusInd Bank acquires 7.82% stake in Eveready by invoking pledged shares
The bank invoked pledge on 56,83,320 shares forming 7.82 percent of paid-up equity share capital of Eveready Industries.
Moneycontrol
Like
Reply
N
Reputation: 4,721 • Aug 8 3:38 AM
COVID-19 impact: Coal India downgrades FY21 production target to 650-660 million tonne
On commercial mining of coal, Agrawal said it will help introduce a market-linked price mechanism and benefit the state-owned mining behemoth, contrary to speculations.
Moneycontrol
Like
Reply
Overview of Fundamental Analysis l Learn to invest India
Fundamental Analysis (FA) is a holistic approach to study a business. This module will show you how to evaluate a business by studying the different aspects ...
YouTube
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • ABBOTINDIA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization15,505.81
    Enterprise Value13,821.52
    Price to Earnings28.88
    Price to Book Value7.72
    Return on Capital Employed0.37
    Return on Equity0.24
    Face Value10
    Dividend Yield0.01
  • ABBOTINDIA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    25-Nov-19ICICIdirect.comBuy14,600
    26-Aug-19ICICIdirect.comBuy10,190
    12-Oct-18CentrumHold7,250
    20-Dec-17ICICIdirect.comBuy6,850
    6-Feb-17CentrumBuy5,380
    ABBOTINDIA Brokerage Price Target
  • ABBOTINDIA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 1017198173501690016973.3
    Aug 716248.5516298.716079.0516199
    Aug 6162651640016055.5516154.5
    Aug 516414.45167861610016247.2
    Aug 416212.5516449.951600016376.45
  • ABBOTINDIA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹15,510.39
    30 Day Moving Average₹15,568.62
    50 Day Moving Average₹15,837.1
    100 Day Moving Average₹16,130.73
    200 Day Moving Average₹14,579.69
  • ABBOTINDIA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,2992,902.560.14
    Operating Profit525397.310.32
    Profit Before Tax621436.490.42
    Net Income401276.650.45
  • ABBOTINDIA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,0081,6930.19
    Total Liabilities9327350.27
    Total Assets2,9412,4280.21
  • ABBOTINDIA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity153307.22-0.5
    Cash from Investing Activity-215-155.410.38
    Cash from Financing Activity-102-89.760.14
    Net Cash Flow-16562.05-3.66
  • ABBOTINDIA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.170.13
    Return on Equity0.240.2
    Return on Capital Employed0.370.32
  • ABBOTINDIA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.28
    3 Year CAGR Growth in Operating Profit0.49
    3 Year CAGR Growth in EBIDTA0.44
    3 Year CAGR Growth in Net Income0.39
    3 Yr CAGR Growth - Diluted EPS0.39
  • ABBOTINDIA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.01
    5 Year CAGR Growth in Operating Profit2.04
    5 Year CAGR Growth in EBIDTA1.33
    5 Year CAGR Growth in Net Income1.3
    3 Yr CAGR Growth - Diluted EPS1.3
  • ABBOTINDIA - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 8 7:18 AM
    Abbott India Q1 net profit jumps 54% to Rs 180.35 crore
    Moneycontrol
    NewsBot
    Aug 8 6:46 AM
    Abbott India Q1 results: Net profit jumps 54% to Rs 180 crore
    The Economic Times
    NewsBot
    Jul 10 11:03 AM
    Indian pharma market contracts nearly 6% in Q1FY21
    Moneycontrol
    NewsBot
    Jun 15 3:18 AM
    Buy Abbott India; target of Rs 19030: ICICI Direct
    Moneycontrol
    NewsBot
    Jun 10 1:31 AM
    Outperformer rating for Abbott India, target price Rs 18,130: CLSA
    The Economic Times
    NewsBot
    Jun 8 1:43 AM
    Abbott India Q4 net profit declines 1.96% at Rs 110.97 crore
    Moneycontrol
    NewsBot
    Jun 8 11:46 AM
    Abbott India Q4 results: Net profit declines 1.96% at Rs 110.97 crore
    The Economic Times
    NewsBot
    May 12 1:58 AM
    Explainer: What is ELISA test, will it help us scale up COVID-19 surveillance efforts?
    Moneycontrol
    NewsBot
    May 7 6:28 AM
    Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets
    Moneycontrol
    NewsBot
    May 7 5:33 AM
    Drop airlines! Here are top 10 stocks based on Warren Buffett's investment methodology
    Moneycontrol
  • ABBOTINDIA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020